Reports are emerging from the ASCO 2026 conference, which appears to be focusing on various aspects of cancer treatment, including lung cancer. Some outlets are highlighting key studies and trials presented at the conference, which may introduce new standards or strategies for treating certain types of cancer. The conference seems to be covering a range of topics, with some outlets also discussing other cancer-related events and research, such as the use of GLP-1 drugs.